KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesLong-Term Debt IssuancesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

NovoCure (NVCR) Other Gross PP&E Adjustments (2016 - 2026)

NovoCure's Other Gross PP&E Adjustments history spans 13 years, with the latest figure at -$45.5 million for Q1 2026.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 6.26% to -$45.5 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$45.5 million, a 6.26% increase, with the full-year FY2025 number at $48.3 million, up 2.03% from a year prior.
  • Other Gross PP&E Adjustments hit -$45.5 million in Q1 2026 for NovoCure, down from $48.3 million in the prior quarter.
  • Over the last five years, Other Gross PP&E Adjustments for NVCR hit a ceiling of $48.3 million in Q4 2025 and a floor of -$48.5 million in Q1 2025.
  • Historically, Other Gross PP&E Adjustments has averaged -$18.2 million across 5 years, with a median of -$26.3 million in 2023.
  • Biggest five-year swings in Other Gross PP&E Adjustments: skyrocketed 347.62% in 2023 and later tumbled 70.85% in 2025.
  • Tracing NVCR's Other Gross PP&E Adjustments over 5 years: stood at $2.7 million in 2022, then surged by 347.62% to $12.0 million in 2023, then skyrocketed by 295.99% to $47.4 million in 2024, then grew by 2.03% to $48.3 million in 2025, then tumbled by 194.07% to -$45.5 million in 2026.
  • Business Quant data shows Other Gross PP&E Adjustments for NVCR at -$45.5 million in Q1 2026, $48.3 million in Q4 2025, and -$48.4 million in Q3 2025.